

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | receptor recycling (GO:0001881) | 6.14940594 |
| 2 | regulation of short-term neuronal synaptic plasticity (GO:0048172) | 5.63536063 |
| 3 | vocalization behavior (GO:0071625) | 5.18976709 |
| 4 | positive regulation of excitatory postsynaptic membrane potential (GO:2000463) | 5.15708326 |
| 5 | regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor act | 4.99282488 |
| 6 | locomotory exploration behavior (GO:0035641) | 4.95754878 |
| 7 | positive regulation of calcium ion-dependent exocytosis (GO:0045956) | 4.87792812 |
| 8 | synaptic vesicle maturation (GO:0016188) | 4.85188573 |
| 9 | neuron cell-cell adhesion (GO:0007158) | 4.76672778 |
| 10 | protein localization to synapse (GO:0035418) | 4.72692400 |
| 11 | regulation of glutamate receptor signaling pathway (GO:1900449) | 4.56544528 |
| 12 | synaptic vesicle exocytosis (GO:0016079) | 4.53573975 |
| 13 | regulation of ARF protein signal transduction (GO:0032012) | 4.50285437 |
| 14 | glutamate secretion (GO:0014047) | 4.46134152 |
| 15 | ionotropic glutamate receptor signaling pathway (GO:0035235) | 4.45050458 |
| 16 | layer formation in cerebral cortex (GO:0021819) | 4.29399518 |
| 17 | regulation of synaptic vesicle exocytosis (GO:2000300) | 4.25702152 |
| 18 | regulation of cAMP-dependent protein kinase activity (GO:2000479) | 4.23824258 |
| 19 | synaptic vesicle docking involved in exocytosis (GO:0016081) | 4.08453658 |
| 20 | regulation of glucokinase activity (GO:0033131) | 4.01907597 |
| 21 | regulation of hexokinase activity (GO:1903299) | 4.01907597 |
| 22 | exploration behavior (GO:0035640) | 3.98713214 |
| 23 | glutamate receptor signaling pathway (GO:0007215) | 3.96607273 |
| 24 | regulation of N-methyl-D-aspartate selective glutamate receptor activity (GO:2000310) | 3.93797376 |
| 25 | cerebellar Purkinje cell differentiation (GO:0021702) | 3.90604257 |
| 26 | dendritic spine morphogenesis (GO:0060997) | 3.86464917 |
| 27 | regulation of synaptic vesicle transport (GO:1902803) | 3.85494258 |
| 28 | neurotransmitter secretion (GO:0007269) | 3.84934941 |
| 29 | neurotransmitter-gated ion channel clustering (GO:0072578) | 3.84880211 |
| 30 | synaptic transmission, glutamatergic (GO:0035249) | 3.78991269 |
| 31 | regulation of long-term neuronal synaptic plasticity (GO:0048169) | 3.78414147 |
| 32 | neuron recognition (GO:0008038) | 3.73513948 |
| 33 | regulation of neuronal synaptic plasticity (GO:0048168) | 3.70650905 |
| 34 | inositol phosphate catabolic process (GO:0071545) | 3.69999008 |
| 35 | gamma-aminobutyric acid transport (GO:0015812) | 3.69686776 |
| 36 | regulation of inhibitory postsynaptic membrane potential (GO:0060080) | 3.69506173 |
| 37 | negative regulation of protein oligomerization (GO:0032460) | 3.62475773 |
| 38 | neuron-neuron synaptic transmission (GO:0007270) | 3.58822788 |
| 39 | positive regulation of glycolytic process (GO:0045821) | 3.54125601 |
| 40 | lactate metabolic process (GO:0006089) | 3.51256607 |
| 41 | sodium ion export (GO:0071436) | 3.49916254 |
| 42 | proline transport (GO:0015824) | 3.48616483 |
| 43 | axonal fasciculation (GO:0007413) | 3.47257558 |
| 44 | synaptic vesicle endocytosis (GO:0048488) | 3.46963557 |
| 45 | cellular ketone body metabolic process (GO:0046950) | 3.46362695 |
| 46 | negative regulation of organelle assembly (GO:1902116) | 3.43922931 |
| 47 | regulation of excitatory postsynaptic membrane potential (GO:0060079) | 3.42761595 |
| 48 | postsynaptic membrane organization (GO:0001941) | 3.41876302 |
| 49 | long-term memory (GO:0007616) | 3.40802269 |
| 50 | kidney morphogenesis (GO:0060993) | 3.39329926 |
| 51 | behavioral response to nicotine (GO:0035095) | 3.38025407 |
| 52 | dendrite morphogenesis (GO:0048813) | 3.37647985 |
| 53 | activation of protein kinase A activity (GO:0034199) | 3.32355604 |
| 54 | regulation of postsynaptic membrane potential (GO:0060078) | 3.31705968 |
| 55 | positive regulation of membrane potential (GO:0045838) | 3.29425900 |
| 56 | import into cell (GO:0098657) | 3.27799792 |
| 57 | pyrimidine nucleobase catabolic process (GO:0006208) | 3.27644542 |
| 58 | regulation of neurotransmitter secretion (GO:0046928) | 3.26384099 |
| 59 | neuronal action potential propagation (GO:0019227) | 3.25941809 |
| 60 | neurotransmitter transport (GO:0006836) | 3.25144567 |
| 61 | cellular response to epinephrine stimulus (GO:0071872) | 3.19783476 |
| 62 | neuromuscular process controlling balance (GO:0050885) | 3.18262024 |
| 63 | presynaptic membrane assembly (GO:0097105) | 3.18257228 |
| 64 | negative regulation of cytosolic calcium ion concentration (GO:0051481) | 3.18094987 |
| 65 | positive regulation of synapse maturation (GO:0090129) | 3.17663056 |
| 66 | ketone body metabolic process (GO:1902224) | 3.17555444 |
| 67 | regulation of respiratory gaseous exchange by neurological system process (GO:0002087) | 3.16922090 |
| 68 | L-fucose catabolic process (GO:0042355) | 3.16528719 |
| 69 | fucose catabolic process (GO:0019317) | 3.16528719 |
| 70 | L-fucose metabolic process (GO:0042354) | 3.16528719 |
| 71 | positive regulation of dendritic spine morphogenesis (GO:0061003) | 3.15042798 |
| 72 | endocrine pancreas development (GO:0031018) | 3.14844032 |
| 73 | regulation of dendritic spine morphogenesis (GO:0061001) | 3.14280625 |
| 74 | regulation of type B pancreatic cell apoptotic process (GO:2000674) | 3.13727531 |
| 75 | transmission of nerve impulse (GO:0019226) | 3.13685362 |
| 76 | water-soluble vitamin biosynthetic process (GO:0042364) | 3.12325572 |
| 77 | regulation of synapse structural plasticity (GO:0051823) | 3.10902555 |
| 78 | membrane depolarization during cardiac muscle cell action potential (GO:0086012) | 3.08874656 |
| 79 | startle response (GO:0001964) | 3.07618160 |
| 80 | central nervous system projection neuron axonogenesis (GO:0021952) | 3.06551355 |
| 81 | positive regulation of neurotransmitter secretion (GO:0001956) | 3.05826893 |
| 82 | cell migration in hindbrain (GO:0021535) | 3.05659481 |
| 83 | inositol phosphate dephosphorylation (GO:0046855) | 2.99709406 |
| 84 | phosphorylated carbohydrate dephosphorylation (GO:0046838) | 2.99709406 |
| 85 | response to methylmercury (GO:0051597) | 2.99516656 |
| 86 | G-protein coupled glutamate receptor signaling pathway (GO:0007216) | 2.99344108 |
| 87 | nucleobase catabolic process (GO:0046113) | 2.98786310 |
| 88 | negative regulation of hormone biosynthetic process (GO:0032353) | 2.98341658 |
| 89 | polyol catabolic process (GO:0046174) | 2.98014935 |
| 90 | response to histamine (GO:0034776) | 2.95015465 |
| 91 | long-term synaptic potentiation (GO:0060291) | 2.94704134 |
| 92 | glycine transport (GO:0015816) | 2.94366392 |
| 93 | positive regulation of respiratory burst (GO:0060267) | 2.93908521 |
| 94 | regulation of neurotransmitter levels (GO:0001505) | 2.93875935 |
| 95 | response to pheromone (GO:0019236) | 2.93502880 |
| 96 | negative regulation of dendrite development (GO:2000171) | 2.93084645 |
| 97 | positive regulation of dendritic spine development (GO:0060999) | 2.92962399 |
| 98 | auditory behavior (GO:0031223) | 2.92764098 |
| 99 | protein localization to cilium (GO:0061512) | 2.91185524 |
| 100 | clathrin coat assembly (GO:0048268) | 2.89176265 |
| 101 | positive regulation of neurotransmitter transport (GO:0051590) | 2.89169642 |
| 102 | regulation of synaptic plasticity (GO:0048167) | 2.89167020 |
| 103 | negative regulation of synaptic transmission, GABAergic (GO:0032229) | 2.89145280 |
| 104 | gamma-aminobutyric acid signaling pathway (GO:0007214) | 2.89006051 |
| 105 | regulation of neurotransmitter transport (GO:0051588) | 2.88923700 |
| 106 | synapse assembly (GO:0007416) | 2.88699642 |
| 107 | cellular potassium ion homeostasis (GO:0030007) | 2.88593440 |
| 108 | regulation of synaptic transmission, glutamatergic (GO:0051966) | 2.87099155 |
| 109 | L-amino acid import (GO:0043092) | 2.86823581 |
| 110 | keratinocyte development (GO:0003334) | 2.86701684 |
| 111 | presynaptic membrane organization (GO:0097090) | 2.86167527 |
| 112 | positive regulation of synaptic transmission, glutamatergic (GO:0051968) | 2.85367318 |
| 113 | social behavior (GO:0035176) | 2.85337943 |
| 114 | intraspecies interaction between organisms (GO:0051703) | 2.85337943 |
| 115 | regulation of calcineurin-NFAT signaling cascade (GO:0070884) | 2.84113144 |
| 116 | behavioral defense response (GO:0002209) | 2.84021123 |
| 117 | behavioral fear response (GO:0001662) | 2.84021123 |
| 118 | response to epinephrine (GO:0071871) | 2.83358475 |
| 119 | dentate gyrus development (GO:0021542) | 2.82388359 |
| 120 | membrane depolarization (GO:0051899) | 2.82373964 |
| 121 | cellular response to monoamine stimulus (GO:0071868) | 2.81429713 |
| 122 | cellular response to catecholamine stimulus (GO:0071870) | 2.81429713 |
| 123 | membrane hyperpolarization (GO:0060081) | 2.79600998 |
| 124 | learning (GO:0007612) | 2.78504736 |
| 125 | innervation (GO:0060384) | 2.77600397 |
| 126 | neuromuscular process (GO:0050905) | 2.76495250 |
| 127 | detection of light stimulus involved in visual perception (GO:0050908) | 2.74391905 |
| 128 | detection of light stimulus involved in sensory perception (GO:0050962) | 2.74391905 |
| 129 | negative regulation of gluconeogenesis (GO:0045721) | 2.73089118 |
| 130 | nitric oxide mediated signal transduction (GO:0007263) | 2.72345421 |
| 131 | detection of mechanical stimulus involved in sensory perception of sound (GO:0050910) | 2.68842223 |
| 132 | positive regulation of protein autophosphorylation (GO:0031954) | 2.68708774 |
| 133 | insulin secretion (GO:0030073) | 2.66696425 |
| 134 | neuronal action potential (GO:0019228) | 2.65112085 |
| 135 | limb bud formation (GO:0060174) | 2.63346511 |
| 136 | positive regulation of glycogen biosynthetic process (GO:0045725) | 2.59480118 |
| 137 | regulation of calcium ion-dependent exocytosis (GO:0017158) | 2.57497722 |
| 138 | signal peptide processing (GO:0006465) | 2.57445667 |
| 139 | glycerophospholipid catabolic process (GO:0046475) | 2.57354327 |
| 140 | positive regulation of peptide hormone secretion (GO:0090277) | 2.55874911 |
| 141 | membrane depolarization during action potential (GO:0086010) | 2.53930088 |
| 142 | positive regulation of growth hormone secretion (GO:0060124) | 2.51921042 |
| 143 | negative regulation of acute inflammatory response (GO:0002674) | 2.48824260 |
| 144 | positive regulation of peptide secretion (GO:0002793) | 2.48396655 |
| 145 | hindbrain development (GO:0030902) | 2.47563950 |
| 146 | cornea development in camera-type eye (GO:0061303) | 2.47393558 |
| 147 | regulation of neurotransmitter uptake (GO:0051580) | 2.47200143 |
| 148 | positive regulation of insulin secretion (GO:0032024) | 2.47058865 |
| 149 | retinal ganglion cell axon guidance (GO:0031290) | 2.45518505 |
| 150 | reflex (GO:0060004) | 2.41628316 |
| 151 | regulation of action potential (GO:0098900) | 2.41008648 |
| 152 | negative regulation of hormone metabolic process (GO:0032351) | 2.40904306 |
| 153 | spinal cord development (GO:0021510) | 2.39683468 |
| 154 | glycosphingolipid biosynthetic process (GO:0006688) | 2.39657508 |
| 155 | mechanosensory behavior (GO:0007638) | 2.37707449 |
| 156 | regulation of feeding behavior (GO:0060259) | 2.37419090 |
| 157 | positive regulation of meiosis (GO:0045836) | 2.37362880 |
| 158 | dopamine transport (GO:0015872) | 2.36309227 |
| 159 | axoneme assembly (GO:0035082) | 2.36002518 |
| 160 | spinal cord motor neuron differentiation (GO:0021522) | 2.33356245 |
| 161 | inner ear receptor stereocilium organization (GO:0060122) | 2.32924222 |
| 162 | positive regulation of glycogen metabolic process (GO:0070875) | 2.32200860 |
| 163 | fatty acid homeostasis (GO:0055089) | 2.31283531 |
| 164 | brain morphogenesis (GO:0048854) | 2.31267432 |
| 165 | action potential (GO:0001508) | 2.28258990 |
| 166 | nephron tubule morphogenesis (GO:0072078) | 2.27625607 |
| 167 | nephron epithelium morphogenesis (GO:0072088) | 2.27625607 |
| 168 | respiratory chain complex IV assembly (GO:0008535) | 2.27163467 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | EZH2_22144423_ChIP-Seq_EOC_Human | 5.40766551 |
| 2 | GBX2_23144817_ChIP-Seq_PC3_Human | 3.68723716 |
| 3 | GATA1_22025678_ChIP-Seq_K562_Human | 3.00053374 |
| 4 | JARID2_20064375_ChIP-Seq_MESCs_Mouse | 2.71677895 |
| 5 | SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 2.68939234 |
| 6 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 2.64155489 |
| 7 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 2.53449367 |
| 8 | ZFP322A_24550733_ChIP-Seq_MESCs_Mouse | 2.50621123 |
| 9 | REST_21632747_ChIP-Seq_MESCs_Mouse | 2.47321614 |
| 10 | VDR_22108803_ChIP-Seq_LS180_Human | 2.42583299 |
| 11 | DROSHA_22980978_ChIP-Seq_HELA_Human | 2.28158336 |
| 12 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 2.26936214 |
| 13 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 2.26936214 |
| 14 | JARID2_20075857_ChIP-Seq_MESCs_Mouse | 2.24208121 |
| 15 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 2.23457119 |
| 16 | EZH2_27304074_Chip-Seq_ESCs_Mouse | 2.21750634 |
| 17 | SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 2.20109804 |
| 18 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 2.18530886 |
| 19 | RARB_27405468_Chip-Seq_BRAIN_Mouse | 2.18151965 |
| 20 | SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 2.15405783 |
| 21 | * SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 2.14810830 |
| 22 | * MTF2_20144788_ChIP-Seq_MESCs_Mouse | 2.14613180 |
| 23 | CDKN2AIP_20523734_ChIP-Seq_CORTICAL_Neurons | 2.13786174 |
| 24 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 2.10014462 |
| 25 | SALL1_21062744_ChIP-ChIP_HESCs_Human | 2.07699925 |
| 26 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 2.05745593 |
| 27 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 2.03684662 |
| 28 | EZH2_27294783_Chip-Seq_ESCs_Mouse | 2.00609116 |
| 29 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 2.00537685 |
| 30 | RNF2_27304074_Chip-Seq_ESCs_Mouse | 1.90449767 |
| 31 | REST_18959480_ChIP-ChIP_MESCs_Mouse | 1.90398042 |
| 32 | FUS_26573619_Chip-Seq_HEK293_Human | 1.88583134 |
| 33 | SUZ12_27294783_Chip-Seq_ESCs_Mouse | 1.85119369 |
| 34 | AR_21572438_ChIP-Seq_LNCaP_Human | 1.82873094 |
| 35 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 1.78257962 |
| 36 | SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 1.76436583 |
| 37 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 1.75889835 |
| 38 | BCAT_22108803_ChIP-Seq_LS180_Human | 1.75783105 |
| 39 | EWS_26573619_Chip-Seq_HEK293_Human | 1.75548745 |
| 40 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 1.70227893 |
| 41 | MEIS1_26253404_ChIP-Seq_OPTIC_CUPS_Mouse | 1.58291768 |
| 42 | EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.54404741 |
| 43 | SMAD4_21799915_ChIP-Seq_A2780_Human | 1.52570875 |
| 44 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 1.50737268 |
| 45 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 1.50712469 |
| 46 | PCGF2_27294783_Chip-Seq_ESCs_Mouse | 1.44820403 |
| 47 | UBF1/2_26484160_Chip-Seq_FIBROBLAST_Human | 1.43632085 |
| 48 | CBP_20019798_ChIP-Seq_JUKART_Human | 1.43032230 |
| 49 | IRF4_20064451_ChIP-Seq_CD4+T_Mouse | 1.43032230 |
| 50 | TAF15_26573619_Chip-Seq_HEK293_Human | 1.42970571 |
| 51 | SMAD3_21741376_ChIP-Seq_EPCs_Human | 1.42886865 |
| 52 | SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 1.39553889 |
| 53 | P300_19829295_ChIP-Seq_ESCs_Human | 1.39219332 |
| 54 | IGF1R_20145208_ChIP-Seq_DFB_Human | 1.39074301 |
| 55 | SOX2_21211035_ChIP-Seq_LN229_Gbm | 1.34808746 |
| 56 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.34044830 |
| 57 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 1.31827120 |
| 58 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.27353867 |
| 59 | MYC_20876797_ChIP-ChIP_MEDULLOBLASTOMA_Human | 1.26345823 |
| 60 | * GATA1_19941826_ChIP-Seq_K562_Human | 1.26235894 |
| 61 | HOXC9_25013753_ChIP-Seq_NEUROBLASTOMA_BE2-C_Human | 1.25257295 |
| 62 | * AR_19668381_ChIP-Seq_PC3_Human | 1.24836904 |
| 63 | STAT3_23295773_ChIP-Seq_U87_Human | 1.24256537 |
| 64 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 1.24175134 |
| 65 | TP53_22573176_ChIP-Seq_HFKS_Human | 1.23439970 |
| 66 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 1.22892661 |
| 67 | CBX2_27304074_Chip-Seq_ESCs_Mouse | 1.22680106 |
| 68 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 1.21968669 |
| 69 | SUZ12_27294783_Chip-Seq_NPCs_Mouse | 1.21888194 |
| 70 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.21422095 |
| 71 | RNF2_16625203_ChIP-ChIP_MESCs_Mouse | 1.20999306 |
| 72 | EZH2_27294783_Chip-Seq_NPCs_Mouse | 1.20876689 |
| 73 | EWS-ERG_20517297_ChIP-Seq_CADO-ES1_Human | 1.20719137 |
| 74 | PHC1_16625203_ChIP-ChIP_MESCs_Mouse | 1.19917356 |
| 75 | TP53_16413492_ChIP-PET_HCT116_Human | 1.19890802 |
| 76 | TCF4_22108803_ChIP-Seq_LS180_Human | 1.19638087 |
| 77 | FLI1_21867929_ChIP-Seq_TH2_Mouse | 1.19498615 |
| 78 | MYCN_21190229_ChIP-Seq_SHEP-21N_Human | 1.18902691 |
| 79 | GRHL2_25758223_ChIP-Seq_PLACENTA_Mouse | 1.18729821 |
| 80 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.17923896 |
| 81 | AR_25329375_ChIP-Seq_VCAP_Human | 1.17361409 |
| 82 | TCF4_23295773_ChIP-Seq_U87_Human | 1.17315163 |
| 83 | EWS-FLI1_20517297_ChIP-Seq_SK-N-MC_Human | 1.16656677 |
| 84 | NFE2_27457419_Chip-Seq_LIVER_Mouse | 1.16179886 |
| 85 | P53_22387025_ChIP-Seq_ESCs_Mouse | 1.15804297 |
| 86 | SMAD4_21741376_ChIP-Seq_EPCs_Human | 1.15480311 |
| 87 | EBF1_22473956_ChIP-Seq_BONE_MARROW_Mouse | 1.15255233 |
| 88 | * RING1B_27294783_Chip-Seq_ESCs_Mouse | 1.14941250 |
| 89 | HOXA2_22223247_ChIP-Seq_E11.5_EMBRYO_Mouse | 1.14049914 |
| 90 | WT1_25993318_ChIP-Seq_PODOCYTE_Human | 1.13689567 |
| 91 | ARNT_22903824_ChIP-Seq_MCF-7_Human | 1.13312603 |
| 92 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 1.12233267 |
| 93 | TCF3/E2A_22897851_ChIP-Seq_JUKARTE6-1_Human | 1.12099132 |
| 94 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 1.11647155 |
| 95 | NR3C1_23031785_ChIP-Seq_PC12_Mouse | 1.11550231 |
| 96 | NANOG_19829295_ChIP-Seq_ESCs_Human | 1.11519249 |
| 97 | SOX2_19829295_ChIP-Seq_ESCs_Human | 1.11519249 |
| 98 | KDM2B_26808549_Chip-Seq_K562_Human | 1.11379052 |
| 99 | KLF5_20875108_ChIP-Seq_MESCs_Mouse | 1.11190328 |
| 100 | OLIG2_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.10989990 |
| 101 | * GATA1_19941827_ChIP-Seq_MEL_Mouse | 1.10383743 |
| 102 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.09528216 |
| 103 | TAL1_21186366_ChIP-Seq_BM-HSCs_Mouse | 1.08876827 |
| 104 | CDX2_21402776_ChIP-Seq_INTESTINAL-VILLUS_Mouse | 1.07547915 |
| 105 | TOP2B_26459242_ChIP-Seq_MCF-7_Human | 1.07484440 |
| 106 | P53_22127205_ChIP-Seq_FIBROBLAST_Human | 1.06277666 |
| 107 | NR3C1_21868756_ChIP-Seq_MCF10A_Human | 1.06083072 |
| 108 | PRDM14_20953172_ChIP-Seq_ESCs_Human | 1.05745208 |
| 109 | KLF1_20508144_ChIP-Seq_FETAL-LIVER-ERYTHROID_Mouse | 1.04807120 |
| 110 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 1.03907339 |
| 111 | BMI1_23680149_ChIP-Seq_NPCS_Mouse | 1.03826035 |
| 112 | SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.03766600 |
| 113 | RING1B_27294783_Chip-Seq_NPCs_Mouse | 1.03627210 |
| 114 | YAP1_20516196_ChIP-Seq_MESCs_Mouse | 1.03391882 |
| 115 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 1.02529697 |
| 116 | E2F1_18555785_Chip-Seq_ESCs_Mouse | 1.02490443 |
| 117 | RUNX2_22187159_ChIP-Seq_PCA_Human | 1.02389538 |
| 118 | CRX_20693478_ChIP-Seq_RETINA_Mouse | 1.02021055 |
| 119 | CMYC_18555785_Chip-Seq_ESCs_Mouse | 1.01759488 |
| 120 | AHR_22903824_ChIP-Seq_MCF-7_Human | 1.00329501 |
| 121 | ER_23166858_ChIP-Seq_MCF-7_Human | 0.99235177 |
| 122 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 0.99015521 |
| 123 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.98391077 |
| 124 | RCOR3_21632747_ChIP-Seq_MESCs_Mouse | 0.96975808 |
| 125 | ZNF274_21170338_ChIP-Seq_K562_Hela | 0.96737709 |
| 126 | SMAD3_21741376_ChIP-Seq_HESCs_Human | 0.96230059 |
| 127 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 0.95582576 |
| 128 | SMAD3_21741376_ChIP-Seq_ESCs_Human | 0.94480116 |
| 129 | TEAD4_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.93635293 |
| 130 | POU5F1_26923725_Chip-Seq_MESODERM_Mouse | 0.93635293 |
| 131 | TAL1_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.93455856 |
| 132 | TCFCP2L1_18555785_Chip-Seq_ESCs_Mouse | 0.93318644 |
| 133 | CEBPB_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.92986287 |
| 134 | TEAD4_22529382_ChIP-Seq_TROPHECTODERM_Mouse | 0.92955713 |
| 135 | SMAD4_21741376_ChIP-Seq_HESCs_Human | 0.91275068 |
| 136 | NANOG_18555785_Chip-Seq_ESCs_Mouse | 0.90330778 |
| 137 | MEIS1_26923725_Chip-Seq_HEMOGENIC-ENDOTHELIUM_Mouse | 0.90296228 |
| 138 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.89064118 |
| 139 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 0.88686028 |
| 140 | RNF2_27304074_Chip-Seq_NSC_Mouse | 0.87184364 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0004859_abnormal_synaptic_plasticity | 6.25959671 |
| 2 | MP0003880_abnormal_central_pattern | 4.36377245 |
| 3 | MP0003635_abnormal_synaptic_transmissio | 3.87260192 |
| 4 | MP0004270_analgesia | 3.28935758 |
| 5 | MP0002063_abnormal_learning/memory/cond | 3.20606720 |
| 6 | MP0009745_abnormal_behavioral_response | 3.14704174 |
| 7 | MP0002064_seizures | 3.09389754 |
| 8 | MP0005423_abnormal_somatic_nervous | 3.02615838 |
| 9 | MP0009046_muscle_twitch | 2.89617954 |
| 10 | MP0003195_calcinosis | 2.77419220 |
| 11 | MP0002572_abnormal_emotion/affect_behav | 2.76177517 |
| 12 | MP0001440_abnormal_grooming_behavior | 2.65679835 |
| 13 | MP0008877_abnormal_DNA_methylation | 2.64317199 |
| 14 | MP0001486_abnormal_startle_reflex | 2.53179768 |
| 15 | MP0001968_abnormal_touch/_nociception | 2.49695404 |
| 16 | MP0005551_abnormal_eye_electrophysiolog | 2.47445224 |
| 17 | MP0003283_abnormal_digestive_organ | 2.43360571 |
| 18 | MP0002102_abnormal_ear_morphology | 2.41583279 |
| 19 | MP0002734_abnormal_mechanical_nocicepti | 2.38106975 |
| 20 | MP0002272_abnormal_nervous_system | 2.25800661 |
| 21 | MP0003787_abnormal_imprinting | 2.09194744 |
| 22 | MP0000778_abnormal_nervous_system | 2.03164023 |
| 23 | MP0002938_white_spotting | 1.98717431 |
| 24 | MP0003656_abnormal_erythrocyte_physiolo | 1.97245426 |
| 25 | MP0000569_abnormal_digit_pigmentation | 1.96937424 |
| 26 | MP0002067_abnormal_sensory_capabilities | 1.96148992 |
| 27 | MP0001501_abnormal_sleep_pattern | 1.79016497 |
| 28 | MP0002735_abnormal_chemical_nociception | 1.77951949 |
| 29 | MP0002733_abnormal_thermal_nociception | 1.77523831 |
| 30 | MP0004811_abnormal_neuron_physiology | 1.75620637 |
| 31 | MP0004924_abnormal_behavior | 1.75378902 |
| 32 | MP0005386_behavior/neurological_phenoty | 1.75378902 |
| 33 | MP0002184_abnormal_innervation | 1.75355638 |
| 34 | MP0002557_abnormal_social/conspecific_i | 1.72567494 |
| 35 | MP0002736_abnormal_nociception_after | 1.72013555 |
| 36 | MP0002876_abnormal_thyroid_physiology | 1.71967164 |
| 37 | MP0001970_abnormal_pain_threshold | 1.69354003 |
| 38 | MP0009780_abnormal_chondrocyte_physiolo | 1.68602054 |
| 39 | MP0004885_abnormal_endolymph | 1.68237333 |
| 40 | MP0002837_dystrophic_cardiac_calcinosis | 1.67836710 |
| 41 | MP0002822_catalepsy | 1.65146110 |
| 42 | MP0002882_abnormal_neuron_morphology | 1.63535518 |
| 43 | MP0008569_lethality_at_weaning | 1.61645350 |
| 44 | MP0006276_abnormal_autonomic_nervous | 1.61334453 |
| 45 | MP0003121_genomic_imprinting | 1.58496575 |
| 46 | MP0000955_abnormal_spinal_cord | 1.58179427 |
| 47 | MP0002229_neurodegeneration | 1.54867362 |
| 48 | MP0005645_abnormal_hypothalamus_physiol | 1.54336118 |
| 49 | MP0005646_abnormal_pituitary_gland | 1.52176373 |
| 50 | MP0003879_abnormal_hair_cell | 1.51192646 |
| 51 | MP0001944_abnormal_pancreas_morphology | 1.48023081 |
| 52 | MP0002928_abnormal_bile_duct | 1.48013800 |
| 53 | MP0003011_delayed_dark_adaptation | 1.46480458 |
| 54 | MP0003329_amyloid_beta_deposits | 1.46219358 |
| 55 | MP0001986_abnormal_taste_sensitivity | 1.45803265 |
| 56 | MP0001984_abnormal_olfaction | 1.45800557 |
| 57 | MP0002090_abnormal_vision | 1.44484929 |
| 58 | MP0001502_abnormal_circadian_rhythm | 1.42311607 |
| 59 | MP0002066_abnormal_motor_capabilities/c | 1.41802476 |
| 60 | MP0003122_maternal_imprinting | 1.37064685 |
| 61 | MP0005253_abnormal_eye_physiology | 1.36008925 |
| 62 | MP0005220_abnormal_exocrine_pancreas | 1.34542856 |
| 63 | MP0000516_abnormal_urinary_system | 1.31241024 |
| 64 | MP0005367_renal/urinary_system_phenotyp | 1.31241024 |
| 65 | MP0003633_abnormal_nervous_system | 1.30796047 |
| 66 | MP0004043_abnormal_pH_regulation | 1.30654226 |
| 67 | MP0005083_abnormal_biliary_tract | 1.28169888 |
| 68 | MP0003123_paternal_imprinting | 1.27503583 |
| 69 | MP0002163_abnormal_gland_morphology | 1.26508215 |
| 70 | MP0004858_abnormal_nervous_system | 1.26453655 |
| 71 | MP0002152_abnormal_brain_morphology | 1.26132459 |
| 72 | MP0004133_heterotaxia | 1.24821480 |
| 73 | MP0002909_abnormal_adrenal_gland | 1.23117822 |
| 74 | MP0001485_abnormal_pinna_reflex | 1.22903268 |
| 75 | MP0003172_abnormal_lysosome_physiology | 1.22842144 |
| 76 | MP0004142_abnormal_muscle_tone | 1.19214907 |
| 77 | MP0004147_increased_porphyrin_level | 1.18960075 |
| 78 | MP0010386_abnormal_urinary_bladder | 1.17548363 |
| 79 | MP0003631_nervous_system_phenotype | 1.16954923 |
| 80 | MP0008872_abnormal_physiological_respon | 1.14481763 |
| 81 | MP0002693_abnormal_pancreas_physiology | 1.13573761 |
| 82 | MP0006072_abnormal_retinal_apoptosis | 1.13228569 |
| 83 | MP0001529_abnormal_vocalization | 1.13036550 |
| 84 | MP0003119_abnormal_digestive_system | 1.12168981 |
| 85 | MP0000427_abnormal_hair_cycle | 1.10375603 |
| 86 | MP0002751_abnormal_autonomic_nervous | 1.08368616 |
| 87 | MP0004510_myositis | 1.06139520 |
| 88 | MP0005379_endocrine/exocrine_gland_phen | 1.06056438 |
| 89 | MP0002752_abnormal_somatic_nervous | 1.03707333 |
| 90 | MP0003634_abnormal_glial_cell | 1.00239402 |
| 91 | MP0004742_abnormal_vestibular_system | 0.99684789 |
| 92 | MP0002069_abnormal_eating/drinking_beha | 0.97407848 |
| 93 | MP0002160_abnormal_reproductive_system | 0.97309377 |
| 94 | MP0002234_abnormal_pharynx_morphology | 0.96429450 |
| 95 | MP0000631_abnormal_neuroendocrine_gland | 0.94865067 |
| 96 | MP0001188_hyperpigmentation | 0.94342607 |
| 97 | MP0001905_abnormal_dopamine_level | 0.93491414 |
| 98 | MP0003632_abnormal_nervous_system | 0.92302844 |
| 99 | MP0005195_abnormal_posterior_eye | 0.92065094 |
| 100 | MP0000538_abnormal_urinary_bladder | 0.90405788 |
| 101 | MP0005535_abnormal_body_temperature | 0.89160379 |
| 102 | MP0003690_abnormal_glial_cell | 0.87775176 |
| 103 | MP0000566_synostosis | 0.87167015 |
| 104 | MP0000639_abnormal_adrenal_gland | 0.85236370 |
| 105 | MP0002638_abnormal_pupillary_reflex | 0.83194909 |
| 106 | MP0001756_abnormal_urination | 0.80982486 |
| 107 | MP0008875_abnormal_xenobiotic_pharmacok | 0.80968994 |
| 108 | MP0001963_abnormal_hearing_physiology | 0.80967164 |
| 109 | MP0005075_abnormal_melanosome_morpholog | 0.80649980 |
| 110 | MP0004130_abnormal_muscle_cell | 0.79273017 |
| 111 | MP0005448_abnormal_energy_balance | 0.78349171 |
| 112 | MP0010234_abnormal_vibrissa_follicle | 0.76678860 |
| 113 | MP0002078_abnormal_glucose_homeostasis | 0.75693812 |
| 114 | MP0000372_irregular_coat_pigmentation | 0.75387863 |
| 115 | MP0000920_abnormal_myelination | 0.74194403 |
| 116 | MP0004085_abnormal_heartbeat | 0.73909643 |
| 117 | MP0004484_altered_response_of | 0.71834186 |
| 118 | MP0003938_abnormal_ear_development | 0.71725119 |
| 119 | MP0005187_abnormal_penis_morphology | 0.71426601 |
| 120 | MP0008961_abnormal_basal_metabolism | 0.70362626 |
| 121 | MP0005394_taste/olfaction_phenotype | 0.69906681 |
| 122 | MP0005499_abnormal_olfactory_system | 0.69906681 |
| 123 | MP0003861_abnormal_nervous_system | 0.68639472 |
| 124 | MP0000604_amyloidosis | 0.67573204 |
| 125 | MP0008874_decreased_physiological_sensi | 0.65024853 |
| 126 | MP0000751_myopathy | 0.64692366 |
| 127 | MP0001324_abnormal_eye_pigmentation | 0.64333491 |
| 128 | MP0001177_atelectasis | 0.60612106 |
| 129 | MP0010329_abnormal_lipoprotein_level | 0.60107006 |
| 130 | MP0005409_darkened_coat_color | 0.59434717 |
| 131 | MP0004145_abnormal_muscle_electrophysio | 0.58823618 |
| 132 | MP0010769_abnormal_survival | 0.58120556 |
| 133 | MP0010770_preweaning_lethality | 0.57669208 |
| 134 | MP0002082_postnatal_lethality | 0.57669208 |
| 135 | MP0000026_abnormal_inner_ear | 0.56772601 |
| 136 | MP0010768_mortality/aging | 0.55688476 |
| 137 | MP0006292_abnormal_olfactory_placode | 0.54935835 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Focal motor seizures (HP:0011153) | 5.78669825 |
| 2 | Poor eye contact (HP:0000817) | 5.38137902 |
| 3 | Impaired social interactions (HP:0000735) | 4.87246040 |
| 4 | Abnormal social behavior (HP:0012433) | 4.87246040 |
| 5 | * Focal seizures (HP:0007359) | 4.86751696 |
| 6 | Myokymia (HP:0002411) | 4.45225641 |
| 7 | * Epileptic encephalopathy (HP:0200134) | 4.37471301 |
| 8 | Visual hallucinations (HP:0002367) | 4.31375234 |
| 9 | Poikilocytosis (HP:0004447) | 4.23135862 |
| 10 | Tetraparesis (HP:0002273) | 4.14612429 |
| 11 | * Febrile seizures (HP:0002373) | 4.06574733 |
| 12 | Hypoglycemic seizures (HP:0002173) | 3.85958470 |
| 13 | Hyperinsulinemic hypoglycemia (HP:0000825) | 3.76739915 |
| 14 | Supranuclear gaze palsy (HP:0000605) | 3.73856051 |
| 15 | Heterotopia (HP:0002282) | 3.69093175 |
| 16 | Abnormality of the labia minora (HP:0012880) | 3.66782260 |
| 17 | Ketoacidosis (HP:0001993) | 3.60194045 |
| 18 | Progressive cerebellar ataxia (HP:0002073) | 3.56880720 |
| 19 | Congenital stationary night blindness (HP:0007642) | 3.56433134 |
| 20 | Epileptiform EEG discharges (HP:0011182) | 3.55139191 |
| 21 | EEG with generalized epileptiform discharges (HP:0011198) | 3.54759027 |
| 22 | Hypsarrhythmia (HP:0002521) | 3.48109675 |
| 23 | * Generalized tonic-clonic seizures (HP:0002069) | 3.46785525 |
| 24 | Atonic seizures (HP:0010819) | 3.44465133 |
| 25 | Absence seizures (HP:0002121) | 3.41400734 |
| 26 | Pancreatic fibrosis (HP:0100732) | 3.35355560 |
| 27 | Pancreatic cysts (HP:0001737) | 3.33396248 |
| 28 | Hypothermia (HP:0002045) | 3.32119664 |
| 29 | Dialeptic seizures (HP:0011146) | 3.30549565 |
| 30 | Hypoglycemic coma (HP:0001325) | 3.29183708 |
| 31 | Neoplasm of the adrenal cortex (HP:0100641) | 3.27587893 |
| 32 | Cystic liver disease (HP:0006706) | 3.26773635 |
| 33 | Broad-based gait (HP:0002136) | 3.22655519 |
| 34 | Depression (HP:0000716) | 3.17636580 |
| 35 | Hyperventilation (HP:0002883) | 3.17320668 |
| 36 | Molar tooth sign on MRI (HP:0002419) | 3.12017019 |
| 37 | Abnormality of midbrain morphology (HP:0002418) | 3.12017019 |
| 38 | Action tremor (HP:0002345) | 3.08980200 |
| 39 | Cerebral inclusion bodies (HP:0100314) | 3.06746007 |
| 40 | Excessive salivation (HP:0003781) | 3.05245443 |
| 41 | Drooling (HP:0002307) | 3.05245443 |
| 42 | Dysdiadochokinesis (HP:0002075) | 3.04386325 |
| 43 | Nephronophthisis (HP:0000090) | 3.04158122 |
| 44 | Large for gestational age (HP:0001520) | 3.03513871 |
| 45 | Protruding tongue (HP:0010808) | 3.01959552 |
| 46 | Neurofibrillary tangles (HP:0002185) | 2.99941631 |
| 47 | Acanthocytosis (HP:0001927) | 2.99619054 |
| 48 | Postural instability (HP:0002172) | 2.96114802 |
| 49 | Abnormality of the pancreatic islet cells (HP:0006476) | 2.90094766 |
| 50 | Abnormality of endocrine pancreas physiology (HP:0012093) | 2.90094766 |
| 51 | True hermaphroditism (HP:0010459) | 2.89801188 |
| 52 | Hyperglycemia (HP:0003074) | 2.88088977 |
| 53 | Mutism (HP:0002300) | 2.87881180 |
| 54 | Hypomagnesemia (HP:0002917) | 2.86178673 |
| 55 | Abnormality of binocular vision (HP:0011514) | 2.85276973 |
| 56 | Diplopia (HP:0000651) | 2.85276973 |
| 57 | Dyschromatopsia (HP:0007641) | 2.84863194 |
| 58 | Progressive inability to walk (HP:0002505) | 2.84580494 |
| 59 | Truncal ataxia (HP:0002078) | 2.83452735 |
| 60 | Ankle clonus (HP:0011448) | 2.77085165 |
| 61 | Urinary bladder sphincter dysfunction (HP:0002839) | 2.76767666 |
| 62 | Enlarged penis (HP:0000040) | 2.75757807 |
| 63 | Bradykinesia (HP:0002067) | 2.74396187 |
| 64 | Gaze-evoked nystagmus (HP:0000640) | 2.69530271 |
| 65 | Central scotoma (HP:0000603) | 2.67837697 |
| 66 | * Status epilepticus (HP:0002133) | 2.65200991 |
| 67 | Abnormal drinking behavior (HP:0030082) | 2.65018787 |
| 68 | Polydipsia (HP:0001959) | 2.65018787 |
| 69 | Impaired vibration sensation in the lower limbs (HP:0002166) | 2.64070774 |
| 70 | Anxiety (HP:0000739) | 2.62945549 |
| 71 | Abnormality of the renal medulla (HP:0100957) | 2.62157509 |
| 72 | Absent speech (HP:0001344) | 2.58285547 |
| 73 | Ketosis (HP:0001946) | 2.54312188 |
| 74 | Abnormality of macular pigmentation (HP:0008002) | 2.54127173 |
| 75 | Impaired vibratory sensation (HP:0002495) | 2.50464467 |
| 76 | Abnormality of the renal cortex (HP:0011035) | 2.47625370 |
| 77 | Lower limb amyotrophy (HP:0007210) | 2.44501636 |
| 78 | Reticulocytosis (HP:0001923) | 2.39307390 |
| 79 | Symptomatic seizures (HP:0011145) | 2.38478506 |
| 80 | Dysmetria (HP:0001310) | 2.38134754 |
| 81 | Abnormality of ocular smooth pursuit (HP:0000617) | 2.37932846 |
| 82 | Abnormality of the metopic suture (HP:0005556) | 2.37413494 |
| 83 | Abnormality of the corticospinal tract (HP:0002492) | 2.36252579 |
| 84 | Clumsiness (HP:0002312) | 2.35550812 |
| 85 | Blue irides (HP:0000635) | 2.33839443 |
| 86 | Genetic anticipation (HP:0003743) | 2.33664871 |
| 87 | Insomnia (HP:0100785) | 2.32733614 |
| 88 | * Hemiparesis (HP:0001269) | 2.30295971 |
| 89 | Impaired smooth pursuit (HP:0007772) | 2.28498650 |
| 90 | Macroorchidism (HP:0000053) | 2.25884576 |
| 91 | Neuronal loss in central nervous system (HP:0002529) | 2.24649175 |
| 92 | Intention tremor (HP:0002080) | 2.24313553 |
| 93 | Methylmalonic acidemia (HP:0002912) | 2.23437526 |
| 94 | Aqueductal stenosis (HP:0002410) | 2.22979944 |
| 95 | Bony spicule pigmentary retinopathy (HP:0007737) | 2.22427248 |
| 96 | Medial flaring of the eyebrow (HP:0010747) | 2.20737645 |
| 97 | Chronic hepatic failure (HP:0100626) | 2.20504315 |
| 98 | Inability to walk (HP:0002540) | 2.18746905 |
| 99 | Spastic gait (HP:0002064) | 2.17310503 |
| 100 | Fair hair (HP:0002286) | 2.17253092 |
| 101 | Inappropriate behavior (HP:0000719) | 2.16868035 |
| 102 | Agitation (HP:0000713) | 2.15461806 |
| 103 | Intestinal atresia (HP:0011100) | 2.13987507 |
| 104 | Resting tremor (HP:0002322) | 2.13703724 |
| 105 | Amblyopia (HP:0000646) | 2.13264861 |
| 106 | Hamartoma of the eye (HP:0010568) | 2.12233849 |
| 107 | Lower limb muscle weakness (HP:0007340) | 2.10219128 |
| 108 | Abnormality of magnesium homeostasis (HP:0004921) | 2.06282025 |
| 109 | Progressive macrocephaly (HP:0004481) | 2.05780332 |
| 110 | Stereotypic behavior (HP:0000733) | 2.05701835 |
| 111 | Generalized hypopigmentation of hair (HP:0011358) | 2.05575563 |
| 112 | Furrowed tongue (HP:0000221) | 2.04882215 |
| 113 | Tubular atrophy (HP:0000092) | 2.03956952 |
| 114 | Cortical visual impairment (HP:0100704) | 2.03512106 |
| 115 | Termporal pattern (HP:0011008) | 2.03013424 |
| 116 | Insidious onset (HP:0003587) | 2.03013424 |
| 117 | Prominent metopic ridge (HP:0005487) | 2.02053455 |
| 118 | Polyuria (HP:0000103) | 2.01485925 |
| 119 | Type II lissencephaly (HP:0007260) | 2.01414802 |
| 120 | Astrocytoma (HP:0009592) | 2.00934551 |
| 121 | Abnormality of the astrocytes (HP:0100707) | 2.00934551 |
| 122 | Abnormal pancreas size (HP:0012094) | 2.00071941 |
| 123 | Torticollis (HP:0000473) | 1.97720316 |
| 124 | Scotoma (HP:0000575) | 1.97201384 |
| 125 | Polyphagia (HP:0002591) | 1.92888601 |
| 126 | Dysmetric saccades (HP:0000641) | 1.91085370 |
| 127 | Akinesia (HP:0002304) | 1.90489541 |
| 128 | Aplasia/Hypoplasia of the tongue (HP:0010295) | 1.90297449 |
| 129 | Abnormality of the lower motor neuron (HP:0002366) | 1.89852938 |
| 130 | Abnormal eating behavior (HP:0100738) | 1.88682258 |
| 131 | Abnormality of salivation (HP:0100755) | 1.88541957 |
| 132 | Gait imbalance (HP:0002141) | 1.86777004 |
| 133 | Psychosis (HP:0000709) | 1.86292970 |
| 134 | Pancreatic islet-cell hyperplasia (HP:0004510) | 1.86272995 |
| 135 | Fetal akinesia sequence (HP:0001989) | 1.86209582 |
| 136 | Urinary urgency (HP:0000012) | 1.86183926 |
| 137 | Parkinsonism with favorable response to dopaminergic medication (HP:0002548) | 1.86094690 |
| 138 | Abolished electroretinogram (ERG) (HP:0000550) | 1.85439976 |
| 139 | Hepatoblastoma (HP:0002884) | 1.85278509 |
| 140 | Abnormal rod and cone electroretinograms (HP:0008323) | 1.84154501 |
| 141 | Abnormality of the heme biosynthetic pathway (HP:0010472) | 1.83947565 |
| 142 | Limb dystonia (HP:0002451) | 1.82860030 |
| 143 | Sclerocornea (HP:0000647) | 1.82265834 |
| 144 | Insulin-resistant diabetes mellitus (HP:0000831) | 1.80733895 |
| 145 | Muscular hypotonia of the trunk (HP:0008936) | 1.80366679 |
| 146 | Ependymoma (HP:0002888) | 1.80098929 |
| 147 | Adrenal hypoplasia (HP:0000835) | 1.79078318 |
| 148 | Sporadic (HP:0003745) | 1.78768055 |
| 149 | Genital tract atresia (HP:0001827) | 1.78542335 |
| 150 | Shawl scrotum (HP:0000049) | 1.78411987 |
| 151 | Gait ataxia (HP:0002066) | 1.78314062 |
| 152 | Aplasia/Hypoplasia of the fovea (HP:0008060) | 1.77611256 |
| 153 | Hypoplasia of the fovea (HP:0007750) | 1.77611256 |
| 154 | Hypoplasia of the corpus callosum (HP:0002079) | 1.76890874 |
| 155 | Decreased central vision (HP:0007663) | 1.76795891 |
| 156 | * Generalized myoclonic seizures (HP:0002123) | 1.76656682 |
| 157 | Focal dystonia (HP:0004373) | 1.75798337 |
| 158 | Optic nerve hypoplasia (HP:0000609) | 1.75498221 |
| 159 | Chorioretinal atrophy (HP:0000533) | 1.75077211 |
| 160 | Pendular nystagmus (HP:0012043) | 1.74666352 |
| 161 | Increased circulating renin level (HP:0000848) | 1.73677664 |
| 162 | Glioma (HP:0009733) | 1.73592769 |
| 163 | Congenital, generalized hypertrichosis (HP:0004540) | 1.72835559 |
| 164 | Methylmalonic aciduria (HP:0012120) | 1.72826213 |
| 165 | Patellar aplasia (HP:0006443) | 1.71259106 |
| 166 | Late onset (HP:0003584) | 1.70076283 |
| 167 | Keratoconus (HP:0000563) | 1.69439680 |
| 168 | Increased corneal curvature (HP:0100692) | 1.69439680 |
| 169 | Renal cortical cysts (HP:0000803) | 1.69321194 |
| 170 | Hepatic necrosis (HP:0002605) | 1.68732155 |
| 171 | Disproportionate short-trunk short stature (HP:0003521) | 1.67580543 |
| 172 | Metaphyseal dysplasia (HP:0100255) | 1.64856021 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | FRK | 6.91763878 |
| 2 | MARK1 | 4.44379366 |
| 3 | NTRK3 | 3.82959812 |
| 4 | EPHA4 | 3.55877039 |
| 5 | MAP3K4 | 3.23764048 |
| 6 | MAP2K7 | 3.07476914 |
| 7 | MAP3K9 | 2.91926941 |
| 8 | FGFR2 | 2.76418783 |
| 9 | WNK3 | 2.60728403 |
| 10 | RIPK4 | 2.54485673 |
| 11 | DAPK2 | 2.44767895 |
| 12 | MINK1 | 2.16987630 |
| 13 | MAP2K4 | 2.13338876 |
| 14 | BMPR1B | 2.08613304 |
| 15 | NTRK2 | 2.06547149 |
| 16 | CASK | 2.03895342 |
| 17 | SIK2 | 1.89615122 |
| 18 | PAK6 | 1.86814467 |
| 19 | ADRBK2 | 1.73435444 |
| 20 | STK39 | 1.65616390 |
| 21 | WNK4 | 1.65498150 |
| 22 | NUAK1 | 1.65310440 |
| 23 | MAP4K2 | 1.64242994 |
| 24 | MAPK13 | 1.63234083 |
| 25 | TNIK | 1.62993631 |
| 26 | CAMKK1 | 1.62488644 |
| 27 | PRPF4B | 1.61765209 |
| 28 | TRIM28 | 1.48575974 |
| 29 | CDK5 | 1.43942214 |
| 30 | NTRK1 | 1.43274988 |
| 31 | KSR1 | 1.39959397 |
| 32 | SGK2 | 1.38636535 |
| 33 | PLK2 | 1.37866288 |
| 34 | CAMK1G | 1.32963538 |
| 35 | OXSR1 | 1.32540572 |
| 36 | ACVR1B | 1.32429040 |
| 37 | MKNK2 | 1.27911872 |
| 38 | TAOK3 | 1.26689663 |
| 39 | SGK494 | 1.26222921 |
| 40 | SGK223 | 1.26222921 |
| 41 | MAP3K12 | 1.24796753 |
| 42 | GRK5 | 1.23129767 |
| 43 | PASK | 1.21002684 |
| 44 | DAPK1 | 1.20247106 |
| 45 | SGK3 | 1.17007689 |
| 46 | ZAK | 1.15941976 |
| 47 | UHMK1 | 1.15877812 |
| 48 | CSNK1G1 | 1.13683313 |
| 49 | STK38L | 1.13250763 |
| 50 | BRSK2 | 1.10821581 |
| 51 | PNCK | 1.08590726 |
| 52 | PRKCG | 1.04665809 |
| 53 | PHKG2 | 1.03604185 |
| 54 | PHKG1 | 1.03604185 |
| 55 | PLK3 | 1.03344922 |
| 56 | DYRK1A | 1.00873582 |
| 57 | TAOK1 | 1.00814297 |
| 58 | MAP3K6 | 0.98890746 |
| 59 | CSNK1G3 | 0.98447102 |
| 60 | KSR2 | 0.95654068 |
| 61 | FER | 0.94608165 |
| 62 | SGK1 | 0.92988374 |
| 63 | STK38 | 0.90475344 |
| 64 | RET | 0.89702539 |
| 65 | PKN1 | 0.86683310 |
| 66 | CAMK2A | 0.86365404 |
| 67 | PRKD3 | 0.85219706 |
| 68 | NLK | 0.84898125 |
| 69 | CAMKK2 | 0.83961974 |
| 70 | MARK2 | 0.83801677 |
| 71 | STK16 | 0.83609894 |
| 72 | STK11 | 0.83556964 |
| 73 | CAMK1 | 0.83213642 |
| 74 | CAMK1D | 0.80864505 |
| 75 | PRKCZ | 0.79346975 |
| 76 | FES | 0.78921582 |
| 77 | RPS6KA2 | 0.76808846 |
| 78 | GRK1 | 0.76300804 |
| 79 | MAP3K2 | 0.76090559 |
| 80 | WEE1 | 0.74153682 |
| 81 | ADRBK1 | 0.74126429 |
| 82 | CSNK1G2 | 0.73736782 |
| 83 | BMX | 0.72430475 |
| 84 | CSNK1A1L | 0.71626171 |
| 85 | TYRO3 | 0.71248978 |
| 86 | LATS2 | 0.66616846 |
| 87 | ERBB3 | 0.66049981 |
| 88 | RPS6KA3 | 0.64764375 |
| 89 | CDK18 | 0.61400954 |
| 90 | DYRK1B | 0.61147940 |
| 91 | CDK15 | 0.60450783 |
| 92 | ALK | 0.60363652 |
| 93 | CAMK4 | 0.60125979 |
| 94 | PDPK1 | 0.59457765 |
| 95 | PRKAA2 | 0.59289522 |
| 96 | PTK2B | 0.58893496 |
| 97 | CDK14 | 0.57550003 |
| 98 | AKT3 | 0.57134854 |
| 99 | PAK3 | 0.56875380 |
| 100 | PTK2 | 0.56481571 |
| 101 | CDK19 | 0.55796047 |
| 102 | PRKAA1 | 0.55491332 |
| 103 | CSNK1D | 0.55304569 |
| 104 | MAPK10 | 0.54972991 |
| 105 | TIE1 | 0.54798216 |
| 106 | CAMK2D | 0.54582026 |
| 107 | EIF2AK1 | 0.54311844 |
| 108 | TLK1 | 0.54064679 |
| 109 | MAPK12 | 0.54047183 |
| 110 | BCR | 0.53843524 |
| 111 | MAP3K7 | 0.53616629 |
| 112 | BMPR2 | 0.53078519 |
| 113 | CAMK2B | 0.52237280 |
| 114 | PRKCE | 0.50750555 |
| 115 | MAPKAPK5 | 0.50269693 |
| 116 | ERBB2 | 0.50037978 |
| 117 | CDK11A | 0.49766385 |
| 118 | PRKCH | 0.49319412 |
| 119 | FGR | 0.48659693 |
| 120 | PDK1 | 0.48390313 |
| 121 | PINK1 | 0.48317598 |
| 122 | INSRR | 0.48017674 |
| 123 | ROCK1 | 0.46399372 |
| 124 | DYRK2 | 0.44951575 |
| 125 | MAPKAPK3 | 0.42889842 |
| 126 | HIPK2 | 0.42442195 |
| 127 | STK3 | 0.41915403 |
| 128 | VRK1 | 0.41406007 |
| 129 | CSNK1A1 | 0.40989538 |
| 130 | FYN | 0.40251392 |
| 131 | PRKACA | 0.39563154 |
| 132 | PRKCI | 0.37720571 |
| 133 | RIPK1 | 0.37469634 |
| 134 | BRD4 | 0.37427343 |
| 135 | PRKCB | 0.37379859 |
| 136 | BRSK1 | 0.37287237 |
| 137 | MAP2K6 | 0.36799026 |
| 138 | PRKACG | 0.36361834 |
| 139 | FGFR3 | 0.35123412 |
| 140 | PRKG1 | 0.34992425 |
| 141 | ATM | 0.34953439 |
| 142 | CDK3 | 0.34667980 |
| 143 | MAPK8 | 0.34249057 |
| 144 | GSK3B | 0.34035831 |
| 145 | CDC42BPA | 0.33718215 |
| 146 | CSNK1E | 0.30311654 |
| 147 | PRKCA | 0.30224781 |
| 148 | TRPM7 | 0.30131930 |
| 149 | PLK1 | 0.29311106 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 4.88039595 |
| 2 | Nicotine addiction_Homo sapiens_hsa05033 | 3.52767038 |
| 3 | Protein export_Homo sapiens_hsa03060 | 3.46382239 |
| 4 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 3.10251715 |
| 5 | Phototransduction_Homo sapiens_hsa04744 | 3.08135594 |
| 6 | GABAergic synapse_Homo sapiens_hsa04727 | 2.64955649 |
| 7 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 2.50124578 |
| 8 | Olfactory transduction_Homo sapiens_hsa04740 | 2.45825395 |
| 9 | Glutamatergic synapse_Homo sapiens_hsa04724 | 2.43950101 |
| 10 | Circadian entrainment_Homo sapiens_hsa04713 | 2.40431779 |
| 11 | Morphine addiction_Homo sapiens_hsa05032 | 2.39811003 |
| 12 | Salivary secretion_Homo sapiens_hsa04970 | 2.17315626 |
| 13 | Long-term potentiation_Homo sapiens_hsa04720 | 2.06775698 |
| 14 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 1.97073226 |
| 15 | Amphetamine addiction_Homo sapiens_hsa05031 | 1.95889788 |
| 16 | Dopaminergic synapse_Homo sapiens_hsa04728 | 1.90958471 |
| 17 | Cholinergic synapse_Homo sapiens_hsa04725 | 1.75659507 |
| 18 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 1.74025321 |
| 19 | Insulin secretion_Homo sapiens_hsa04911 | 1.72780874 |
| 20 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 1.67533550 |
| 21 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 1.66307237 |
| 22 | Tryptophan metabolism_Homo sapiens_hsa00380 | 1.61659818 |
| 23 | Gastric acid secretion_Homo sapiens_hsa04971 | 1.60036787 |
| 24 | Selenocompound metabolism_Homo sapiens_hsa00450 | 1.59025795 |
| 25 | Homologous recombination_Homo sapiens_hsa03440 | 1.54940957 |
| 26 | Serotonergic synapse_Homo sapiens_hsa04726 | 1.53981273 |
| 27 | Taste transduction_Homo sapiens_hsa04742 | 1.53170660 |
| 28 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 1.50165883 |
| 29 | Propanoate metabolism_Homo sapiens_hsa00640 | 1.47086679 |
| 30 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 1.45308198 |
| 31 | Calcium signaling pathway_Homo sapiens_hsa04020 | 1.43749262 |
| 32 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 1.43645783 |
| 33 | Renin secretion_Homo sapiens_hsa04924 | 1.43073438 |
| 34 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 1.41999270 |
| 35 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 1.41746817 |
| 36 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 1.39879892 |
| 37 | Long-term depression_Homo sapiens_hsa04730 | 1.39642301 |
| 38 | Cocaine addiction_Homo sapiens_hsa05030 | 1.38849589 |
| 39 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 1.34798962 |
| 40 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 1.33228665 |
| 41 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 1.31847031 |
| 42 | Gap junction_Homo sapiens_hsa04540 | 1.30530422 |
| 43 | GnRH signaling pathway_Homo sapiens_hsa04912 | 1.28377475 |
| 44 | Regulation of autophagy_Homo sapiens_hsa04140 | 1.27462440 |
| 45 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 1.26645571 |
| 46 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 1.24151201 |
| 47 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 1.22590960 |
| 48 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 1.22304109 |
| 49 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 1.18290574 |
| 50 | cAMP signaling pathway_Homo sapiens_hsa04024 | 1.13817740 |
| 51 | Axon guidance_Homo sapiens_hsa04360 | 1.13331770 |
| 52 | Ether lipid metabolism_Homo sapiens_hsa00565 | 1.12983737 |
| 53 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.10936265 |
| 54 | Nitrogen metabolism_Homo sapiens_hsa00910 | 1.10034590 |
| 55 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 1.09432465 |
| 56 | ErbB signaling pathway_Homo sapiens_hsa04012 | 1.08899064 |
| 57 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 1.04605885 |
| 58 | Bile secretion_Homo sapiens_hsa04976 | 1.01877536 |
| 59 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 1.01507769 |
| 60 | Glioma_Homo sapiens_hsa05214 | 1.00878490 |
| 61 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.96794907 |
| 62 | Basal transcription factors_Homo sapiens_hsa03022 | 0.95874144 |
| 63 | ABC transporters_Homo sapiens_hsa02010 | 0.94458629 |
| 64 | Fatty acid metabolism_Homo sapiens_hsa01212 | 0.93872289 |
| 65 | Peroxisome_Homo sapiens_hsa04146 | 0.92181049 |
| 66 | Non-homologous end-joining_Homo sapiens_hsa03450 | 0.92004161 |
| 67 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 0.91577964 |
| 68 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.90883573 |
| 69 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 0.90775648 |
| 70 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.87058570 |
| 71 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.86720588 |
| 72 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 0.85897989 |
| 73 | Parkinsons disease_Homo sapiens_hsa05012 | 0.85206679 |
| 74 | Melanogenesis_Homo sapiens_hsa04916 | 0.82256690 |
| 75 | Steroid biosynthesis_Homo sapiens_hsa00100 | 0.80632262 |
| 76 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.80318428 |
| 77 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.79660230 |
| 78 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.78793926 |
| 79 | Fatty acid elongation_Homo sapiens_hsa00062 | 0.77692372 |
| 80 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 0.75235516 |
| 81 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.74938389 |
| 82 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.73216852 |
| 83 | Fatty acid degradation_Homo sapiens_hsa00071 | 0.71753722 |
| 84 | Lysine degradation_Homo sapiens_hsa00310 | 0.71634113 |
| 85 | Circadian rhythm_Homo sapiens_hsa04710 | 0.71498565 |
| 86 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.69826996 |
| 87 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.69175036 |
| 88 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.67658877 |
| 89 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.67543998 |
| 90 | One carbon pool by folate_Homo sapiens_hsa00670 | 0.67433397 |
| 91 | Alzheimers disease_Homo sapiens_hsa05010 | 0.66277205 |
| 92 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 0.64598205 |
| 93 | Retinol metabolism_Homo sapiens_hsa00830 | 0.64343299 |
| 94 | RNA polymerase_Homo sapiens_hsa03020 | 0.62667435 |
| 95 | RNA degradation_Homo sapiens_hsa03018 | 0.62606366 |
| 96 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 0.62281546 |
| 97 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.61741542 |
| 98 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.60926266 |
| 99 | Sulfur metabolism_Homo sapiens_hsa00920 | 0.60889438 |
| 100 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 0.59919805 |
| 101 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.59713784 |
| 102 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.58997663 |
| 103 | Hedgehog signaling pathway_Homo sapiens_hsa04340 | 0.58385895 |
| 104 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.57873796 |
| 105 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 0.57639018 |
| 106 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.57193500 |
| 107 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.57017913 |
| 108 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.56036759 |
| 109 | Mineral absorption_Homo sapiens_hsa04978 | 0.55039210 |
| 110 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.54816100 |
| 111 | Prion diseases_Homo sapiens_hsa05020 | 0.53631588 |
| 112 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 0.53299149 |
| 113 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 0.53076958 |
| 114 | Arginine biosynthesis_Homo sapiens_hsa00220 | 0.52975566 |
| 115 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.52580272 |
| 116 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.52575063 |
| 117 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.51927695 |
| 118 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.50700741 |
| 119 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 0.50598272 |
| 120 | Butanoate metabolism_Homo sapiens_hsa00650 | 0.50167691 |
| 121 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 0.49810960 |
| 122 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 0.48919501 |
| 123 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.48586449 |
| 124 | Endometrial cancer_Homo sapiens_hsa05213 | 0.48447971 |
| 125 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.47937185 |
| 126 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.47409567 |
| 127 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.45156144 |
| 128 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.44428229 |
| 129 | Ras signaling pathway_Homo sapiens_hsa04014 | 0.44343494 |
| 130 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.42769145 |
| 131 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.42591503 |
| 132 | Metabolic pathways_Homo sapiens_hsa01100 | 0.42137762 |
| 133 | Huntingtons disease_Homo sapiens_hsa05016 | 0.40522326 |
| 134 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.39957966 |
| 135 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.39268112 |
| 136 | Oocyte meiosis_Homo sapiens_hsa04114 | 0.38593408 |
| 137 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.38173339 |
| 138 | Alcoholism_Homo sapiens_hsa05034 | 0.37688905 |
| 139 | Basal cell carcinoma_Homo sapiens_hsa05217 | 0.37197026 |
| 140 | Endocytosis_Homo sapiens_hsa04144 | 0.36925428 |
| 141 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.35558716 |
| 142 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 0.35147684 |
| 143 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 0.32267433 |
| 144 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.31109508 |
| 145 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.30401909 |
| 146 | Wnt signaling pathway_Homo sapiens_hsa04310 | 0.29557032 |
| 147 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.29546826 |
| 148 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 0.29420941 |

